Embody vs Maximus: Low-Cost GLP-1 Options Compared

Embody vs Maximus: if price and speed matter most, Embody offers a lower entry price for compounded semaglutide; Maximus provides a midrange flat rate with U.S. pharmacy sourcing. Early verdict: Embody is the cheapest entry point, while Maximus emphasizes licensed-doctor approvals and trusted U.S. pharmacies.

See Embody pricing and start the process

Key differences at a glance in the Embody vs Maximus comparison

This comparison focuses on the most distinctive supported differences: monthly price, medication sourcing and compounding status, shipping speed and refund policy, clinician approval and telemedicine access, and availability or reach.

1. Monthly price and entry offer

Embody: Lists compounded semaglutide at $69/month, reduced from $299, and compounded tirzepatide at $119/month. Maximus: Lists semaglutide at $132.99/month as a low flat rate. These are direct-pay prices; final pricing for Embody may vary based on dose and clinician recommendation and the $69 semaglutide pricing is a limited-time offer that may increase.

Compare Embody options and current price

2. Medication sourcing and regulatory note

Both providers offer compounded medication only and do not provide branded Ozempic, Wegovy, or Zepbound. The regulatory note for both: compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Maximus highlights that prescriptions are filled through trusted U.S. pharmacies. Embody describes its offerings as compounded semaglutide and compounded tirzepatide.

3. Clinician review, telemedicine, and approvals

Embody: Prescription and telemed visits included; licensed provider review handled entirely online. Maximus: Prescriptions are approved by licensed doctors via telemedicine with no clinic visits. Maximus states that if you are not approved for treatment, medication costs will be fully refunded.

See Maximus telemedicine and approval details

4. Shipping speed, refunds, and availability

Embody promises free shipping with delivery in 1 to 2 days after clinician approval. Maximus offers free priority expedited shipping and notes a refund if you are not approved. Maximus also states its Weight Loss Protocol is currently available in all 50 states except Mississippi.

Comparison table: Embody vs Maximus

How features affect choice

Budget minded patients looking for the lowest announced entry price will see Embody as the cheaper option based on the $69/month semaglutide claim and $119/month tirzepatide claim. Patients who prioritize U.S. pharmacy sourcing and an explicit refund if not approved may prefer Maximus at $132.99/month. Both operate via telemedicine and both use compounded medication, with the same regulatory note about compounded products not being FDA-approved finished products.

Check Maximus availability and start the intake

Final thoughts on Embody vs Maximus

In the Embody vs Maximus comparison, Embody is presented as the lower-cost, fast-shipping option with a limited-time $69/month semaglutide offer and 1 to 2 day delivery after approval. Maximus presents a steady $132.99/month rate, licensed-doctor approvals, trusted U.S. pharmacy fulfillment, free priority shipping, and a stated refund policy if not approved. Both use compounded medication that are not FDA-approved finished products.

Choose Embody if you want the lowest advertised entry price for compounded semaglutide and rapid 1 to 2 day shipping after clinician approval.

Choose Maximus if you prefer prescriptions filled through trusted U.S. pharmacies with licensed-doctor approvals and an explicit refund if you are not approved.